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Background: Due to the increasing importance of quality of life assessments in chronic
obstructive pulmonary disease (COPD) patients, and the increased use of the International
Classification of Functioning, Disability and Health (ICF) for comparative purposes it is
essential to understand the relationship between health-related quality of life (HRQL)
instruments and the ICF.
Objective: The objective of this study was to compare the content of recommended
COPD-specific HRQL instruments using the ICF as reference. COPD-specific instruments
mentioned in widely accepted guidelines were linked to the ICF using standardized linking
rules. The degree of agreement between various health professionals was assessed by
calculating the kappa statistic.
Results: Eleven instruments were included. They varied strongly in the number of
concepts contained and the number of ICF categories used to map these concepts.
A total of 548 concepts were identified and linked to 60 different ICF categories. Only the
single category ‘dyspnea’ was covered by all instruments, whilst 21 categories were
unique to specific instruments. The relationships of the measures with the ICF were
identified.Elsevier Ltd. All rights reserved.
of Physical Medicine and Rehabilitation, Ludwig-Maximilian University, 81377 Munich, Germany.
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A. Stucki et al.1114Conclusions: This study may aid researchers and clinicians to choose the most appropriate
instrument for a specific purpose as well as help compare studies that have used different
instruments for HRQL assessment.
& 2006 Elsevier Ltd. All rights reserved.Introduction
The rising prevalence of chronic obstructive pulmonary
disease (COPD) is increasingly evident worldwide. Due to the
ageing of the population and the increase in disease
prevalence, COPD is projected to become the fifth leading
cause of years lived with disability and the third most
common cause of death by 2020.1
From a societal and patient perspective, COPD is
associated with increased healthcare costs2 and decreased
quality of life.3 Quality of life of patients suffering from the
multiple structural and functional changes is increasingly
being accepted as one of the most important health
outcomes to consider in managing the disease. Conse-
quently, improving quality of life is considered a major goal
in widely recognized guidelines for the management of
COPD, such as those of the British Thoracic Society (BTS)4
and the European Respiratory Society (ERS).5 More recently,
the GOLD guidelines, issued by the US National Heart, Lung,
and Blood Institute and the World Health Organization,6,7
identified the goals of effective COPD management, which
included relief of symptoms, improving exercise tolerance
and quality of life. Similarily, numerous societies’ guidelines
for pulmonary rehabilitation—among them the BTS,8 the
ERS,9,10 the American Thoracic Society (ATS),10,11 the
American College of Chest Physicians (ACCP) and the
American Association of Cardiovascular and Pulmonary
Rehabilitation (AACPR)12—consider quality of life a major
goal in patients with COPD.
The recognition of the importance of systematically
assessing symptoms and functional limitations in order to
optimize the management of COPD has led to the develop-
ment and use of numerous condition-specific health-related
quality of life (HRQL) instruments. None of the aforemen-
tioned organizations has made recommendations regarding
the use of specific HRQL instruments, in part because of
insufficient comparative data. The need to perform head-to-
head comparisons and to develop specific and standardized
methods to enhance the interpretability of HRQL instru-
ments for clinicians was identified at an ATS-sponsored
conference on measuring health outcomes for patients with
COPD,13 and has been emphasized in review articles.14
When selecting HRQL instruments for research or clinical
settings, the validity, practicability, and discrimination of
the potential HRQL instruments are to be considered and
compared. Some COPD-specific HRQL instruments have been
compared and reviewed in detail.14–16 Detailed content
comparisons are hardly to be found in the literature. This is
likely due to the variable use of concepts, scales, and items
in the different COPD-specific HRQL instruments, and the
lack of a common framework and terminology. With thenewly available International Classification of Functioning,
Disability and Health (ICF),17 a universal framework exists in
which the items and scales of various HRQL instruments can
better be compared.18,19 Interestingly, the International
Classification of Impairments, Disabilities, and Handicaps
(ICIDH), the predecessor of the ICF, was already considered
‘‘suitable for categorizing much of the morbidity arising
from respiratory diseases’’ according to the old ATS’s official
statement on pulmonary rehabilitation.11
Since the ICF is being increasingly applied in clinical
research and practice, it will likely be used in future clinical
and epidemiological trials, as well as in health reports or
serve as a reference for comparative studies. A combination
of both the ICF and the disease-specific HRQL instruments
could be applied simultaneously.
The objective of our study was to examine and to
compare the contents of HRQL instruments used in COPD,
using the ICF as the frame of reference and to identify the
relationship of the instruments with the ICF.Methods
To compare the most widely used and recommended COPD-
specific HRQL instruments we (1) identified and selected the
HRQL instruments mentioned in major national and inter-
national COPD guidelines and reviews, (2) linked the
concepts contained in the HRQL instruments to the ICF,
and (3) compared the contents covered by the different
HRQL instruments.Selection of HRQL instruments
Multiple sources were used to identify disease-specific HRQL
instruments in COPD: (i) guidelines for the management and
rehabilitation of COPD, as set forth by British Societies,4,8,20
the European Respiratory Society,5 and the American
Thoracic Society11,21; (ii) the GOLD Guidelines6; (iii) the
pulmonary rehabilitation guidelines published by the ACCP
and AACPR,12 and their updates7,22; and (iv) COPD-specific
HRQL instruments cited in the recently published re-
views.14,16 When more than one version was available, the
most recent version was studied.23The international classification of functioning,
disability and health, ICF
The ICF (formerly ICIDH–2, http://www3.who.int/icf/
icftemplate.cfm) was developed in a comprehensive con-
sensus process conducted worldwide over the past few
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Comparison of HRQL instruments for COPD 1115years. Endorsement by the World Health Assembly occurred
in May 2001.
The overall aim of the ICF classification is to provide a
unified and standard language and framework for the
description of health and health-related states. The ICF
encompasses all aspects of human health and health-
relevant components of well-being, and describes situations
involving human functioning and its restrictions. The ICF
serves as a framework to organize this information in a
meaningful, interrelated, and easily accessible way.
The overall structure of the ICF is shown in Fig. 1. The two
main subdivisions cover Functioning & Disability (Part 1) and
Contextual Factors (Part 2). Each of these two subdivisions
is further divided into ‘components’: (i) Body Functions, (ii)
Body Structures, (iii) Activities and Participation, (iv)
Environmental Factors, and (v) Personal Factors. The letters
b, s, d, e and pf refer to the components ‘Body Functions’
(b), ‘Body Structures’ (s), ‘Activities and Participation’ (d),
‘Environmental Factors’ (e) and ‘Personal Factors’ (pf). The
letters are followed by a numeric code that defines the
chapter number (first digit) and the category levels up to the
fourth level (suffix of two, three, or four digits). Categories
are the units of the ICF classification. They are arranged in a
stem–branch–leaf scheme, so that a lower-level category
shares the attributes of the higher level of which it is a
member. For further information on the conceptual back-
ground, underlying definitions and structure of the ICF, we
refer to the respective WHO publication.17Linking of HRQL instruments to the ICF
In order to compare the content of the various COPD-specific
HRQL instruments, we first linked each instrument to the
ICF. The detailed classification, including all categories with
their definitions and inclusion and exclusion criteria, was
applied throughout the linking procedure.
The linking procedure was performed independently by
two groups, each made up of three healthcare professionals.ICF
Part 1: Functioning and Disability
Body Functions
and Structures
Activities and
Participation
Item levels
- 1 st
- 2nd
- 3rd & 4th
Item levels
-1st
- 2nd
-3rd & 4th
Figure 1 Structure of the International Classification of Functionin
item level), categories can be discriminated (i.e., 2nd–4th item levGroup 1 consisted of three psychologists with experience in
quality of life and outcomes research. Group 2 included
three medical doctors from diverse backgrounds: respiratory
medicine (AS), public health (JR), and physical medicine and
rehabilitation (GS).
Both groups were trained in the use of the ICF and were
familiar with the HRQL instruments. They followed the
coding guidelines described in the Annex two of the ICF17
and a standardized linking approach.19,24 In addition, (i) a
version of each measure and the ICF was available to each
group member, (ii) the two groups identified the concepts
covered by each item of the HRQL instruments indepen-
dently, (iii) the identified concepts were linked to the ICF
categories that most precisely covered the concepts of each
of the items (for examples see Table 1), and (iv) the two
groups’ results were compared and kappa statistics per-
formed. In case of disagreement, results were discussed
between the two groups and a consensus was reached for
the final version.Data analyses and content comparison
The documentation of the linkage process and data manage-
ment were conducted using a simple database. The
reliability of the linkage process was evaluated by calculat-
ing kappa coefficients and 95% bootstrap confidence inter-
vals based on the two independent linkage versions of each
instrument. Kappa statistics were calculated per compo-
nent, at the 1st (chapter) and 2nd (category) ICF levels to
indicate the degree of agreement between the two groups
of health professionals conducting the linkage procedure.
The kappa analysis was performed with SAS.
In a first step, the identified concepts from the instru-
ments are described according to their frequency distribu-
tion across the ICF components. In a second step, the
identified concepts from the instruments are described
according to their frequency distribution across the ad-
dressed ICF chapters (1st level) and categories (2nd level).Part 2: Contextual Factors
Personal
Factors
Environmental
Factors
Classification
Parts
Components
Item levels
-1st
- 2nd
- 3rd & 4th
Chapter level
g, Disability and Health (ICF). Within the chapters (i.e., the first
el).
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A. Stucki et al.1116According to the guidelines of each of the ethics commit-
tees (University of Bern, Switzerland and Ludwig-Maximilian
University, Munich, Germany) approval was not necessary.
Results
Selected HRQL instruments
Altogether, 11 COPD-specific HRQL instruments were identi-
fied: (1) the St. George’s respiratory questionnaire
(SGRQ),25 (2) the chronic respiratory questionnaire, stan-
dardized version (CRQ-SAS),23 (3) the pulmonary functional
status & dyspnea questionnaire, modified version (PFSDQ-
M),26 (4) the pulmonary functional status scale (PFSS),27 (5)
the breathing problems questionnaire (BPQ)28 (the shor-
tened version BPQ-S was not chosen as it exclusively applies
to patients in rehabilitation settings), (6) the Seattle
obstructive lung disease questionnaire (SOLDQ),29 (7) the
quality of life for respiratory illness questionnaire (QOL-
RIQ),30 (8) the airway questionnaires 20 (AQ20),31 (9) the
London chest activity of daily living scale (LCADL),32 (10) the
Maugeri Foundation respiratory failure questionnaire
(MRF28),33 and (11) the clinical COPD questionnaire (CCQ).34
Linking process
Examples of the results after application of the coding and
linking procedure are shown in Table 1. Terms referring to a
time sequence, including ‘in the last 2 weeks’ or ‘day-to-day
problems’, cannot be linked to the ICF and were assigned nd
(not definable). Terms such as ‘your chest condition’, ‘your
lung disease’ were used in many items as a substitute or
umbrella term for the underlying disease and were assigned
hc (health condition). Health conditions are classified and
coded in the complementary International Classification of
Diseases, ICD 10 (example given in Table 1).
Linking results
Table 2 shows the results of the evaluation of the linkage
procedure by kappa statistics and bootstrapped confidence
intervals. Estimated kappa values range from 0.81 to 0.92.
None of the 95% confidence intervals encloses zero, thus
linker agreement exceeds chance.
Table 3 shows the number of identified concepts from the
selected instruments as well as summarized for all instru-
ments. The table also includes the concepts’ distributionTable 2 Estimated kappa coefficient and the boot-
strapped confidence intervals at the component, 1st
(chapter) and 2nd (category) ICF levels.
Estimated
kappa
coefficient
95% Bootstrapped
confidence
intervals
Component 0.58 [0.51;0.64]
Chapter 1st level 0.69 [0.64;0.74]
2nd level 0.72 [0.68;0.77]
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Comparison of HRQL instruments for COPD 1117across the ICF components, as well as the number of
concepts not covered by the ICF. Within the 11 selected
instruments 548 concepts have been identified. The SGRQ
contains the highest (n ¼ 105) and the CCQ the lowest
number of concepts (n ¼ 24). All HRQL instruments covered
the ICF components ‘body functions’ and ‘activities and
participation’ and none of the component ‘body structure’.
‘Environmental factors’ are not covered by CRQ-SAS,
PFSDQ-M, CCQ and ‘personal factors’ are not covered by
PFSDQ-M, LCADL, CCQ.
Most concepts (n ¼ 255) have been linked to ICF
categories from the component ‘Activity and Participation’.
In contrast, only 38 of the concepts (6.9%) has been linked to
‘Environmental Factors’. Three concepts could not be linked
by the ICF; ‘unpleasant side effects from medication’
(SGRQ), ‘production of phlegm’ (SGRQ, CCQ), and ‘current
treatment’ (SOLQ).
Table 4 shows the linkage of the concepts to the ICF
categories ‘body functions’, Table 5 to ‘activities and
participation’, and Table 6 to ‘environmental factors’. The
numbers contained in the tables represent the frequency
with which the ICF categories were addressed in the
different HRQL instruments. While the number of concepts
linked to a specific ICF category can provide insights into this
issue, no conclusion regarding the psychometric properties
and the suitability of the instrument for a specified purpose
can be made. A higher number may indicate that either the
instrument contains a determined concept more than once
or that the ICF classification did not differentiate that
concept in greater detail, and therefore several items from
a specific instrument had to be linked to the same ICF
category. For example, in the CRQ-SAS the ICF category
emotional functions (b152), which may include positive and
negative aspects, was chosen to link a number of different
states such as ‘‘angry or upset’’, ‘‘feeling of fear or panic’’,
‘‘feeling worried or depressed’’, or ‘‘feeling relaxed, free of
tension, satisfied’’. If the ICF would have more refined
categories for these different states, the named items
would have been linked to these categories.
A total of 60 different ICF categories (2nd level)
corresponding to 4.1% of all existing ICF categories have
been used to map the contents of the 11 instruments.
The instrument with the broadest bandwidth of content
coverage is the SGRQ. To link the concepts of the SGRQ 33
different ICF categories have been used.
The content of the identified items that cover ‘personal
factors’ refers to coping strategies, personal wishes, help-
lessness, and dependences.Discussion
This paper selected the most widely used instruments to
evaluate COPD patients, examined the content by linking
the concepts to the ICF, and in the process generated an
inventory, which can contribute to the understanding of the
content of the current instruments in relation to the ICF. The
instruments studied varied strongly in the number of
concepts they contain and the number of ICF categories
used to map these concepts.
A total of 60 different ICF categories were used to map
the contents of the 11 instruments. Only one category,
ARTICLE IN PRESS
Table 4 Linkage of concepts from COPD-specific HRQL instruments to the respective ICF categories in the component body
functions.
ICF component body functions (b) Instruments
 Category SGRQ CRQ-SAS PFSDQ-M PFSS BPQ SOLDQ QOL-RIQ AQ20 LCADL MRF28 CCQ
b1 b110 Consciousness
function
1
b126 Personality functions 1 1 3 1 2 1
b130 Energy and drive
functions
1 5 15 1 1 3 1 2
b134 Sleep functions 1 2 2 1 1
b140 Attention function 1
b144 Memory functions 3
b147 Psychomotor
functions
1 1 1 1
b152 Emotional functions 3 10 6 4 6 6 6 5 1 2
b2 b265 Touch functions 1
b280 Sensation of pain 1
b289 Sensation of pain,
unspecified
1
b3 b340 Alternative
vocalization functions
1
b4 b410 Heart functions,
tachycardia
1
b440 Respiration functions 11 1 1 3 4 2 1 6
b450 Cough 5 1 1 2 1 2
b455 Exercise tolerance
functions
3 1 1 3
b460 Dyspnea 14 8 15 2 4 7 2 7 17 5 2
Wheezing 2 1
b469 Functions, sensations
of the respiratory system,
unspecified
3 1 1
b6 b640 Sexual functions 3 3
b8 b840 Sensations of pins and
needles
1
The figures depict the number of items within the instrument that contained concepts linked to the respective ICF category.
Chapters: b1 (mental functions), b2 (sensory functions and pain), b3 (voice and speech functions), b4 (functions of the
cardiovascular, haematological, immunological and respiratory systems), b5 (functions of the digestive, metabolic and endocrine
systems), b6 (genitourinary and reproductive functions), b8 (functions of the skin and related structures).
A. Stucki et al.1118dyspnea (b460) was addressed by all instruments. By linking
all instruments to the ICF it could be shown that the
classification is a very precise tool with few exceptions. The
precision can be illustrated by, for example, the item
‘breathing problems when exposed to flowers, trees, plants’
of the QOL-RIQ (item 7, section ‘circumstances that might
trigger chest problems’), which is well represented by the
ICF category e220.
Within the component body functions we found most
similarities regarding the contents addressed in the chapter
mental (b1), and respiratory and cardiovascular functions
(b4). Considering the most frequent clinical symptoms of
COPD,6 it is obvious that all HRQL instruments clarify the
impact of dyspnea, addressed by category b460. Similarly,
anxiety and depression show a high prevalence in patients
with COPD. Therefore, it is not surprising that all but one
instrument covered these contents, which are addressed in
the ICF category b152. While we found similarities in these
exemplified main health domains, there are striking
differences in what is considered further relevant within
this component. For example, some clinically highly
relevant symptoms, such as coughing (b450), were notcovered by four instruments. However, since cough and
phlegm is of questionable relevance for very severe COPD it
may not have been included in the MRF 28 and the LCADL,
developed for the most severe COPD patients. It is
noteworthy, that only the SGRQ and the CCQ refer to the
production of phlegm. This is remarkable, since it is well
known that exacerbations are more frequent in those COPD
patients with regular sputum production. Similarly, clinical
assessment of health status in all patients with COPD should
include questions about sleep quality and possible co-
existing sleep apnoea syndrome.22 However, sleep functions
(b134) were assessed by six instruments only.
Within the component activities and participation, it
becomes obvious that patients with COPD face a number of
problems regarding walking (d450), climbing (d455), lifting
and carrying objects (d430), covered by most HRQL
instruments. Other important consequences of exercise
intolerance include increased difficulty in washing oneself
(d510), dressing (d540), shopping (d620), doing housework
(d610), and playing sports or games (d920). These activities
are part of the chapters mobility (d4), self-care (d5),
domestic (d6), and social life (d9) and consistent with the
ARTICLE IN PRESS
Table 5 Linkage of concepts from COPD-specific HRQL instruments to the respective ICF categories in the component
activity and participation.
ICF component activity and participation (d) Instruments
 Category SGRQ CRQ-SAS PFSDQ-M PFSS BPQ SOLDQ QOL-RIQ AQ20 LCADL MRF28 CCQ
Activity and participation (global) 1 2 2 1
d2 d230 Carrying out daily routine 2 2 3 1 1 1
d3 d330 Speaking (talking) 1 1 2 1
d4 d410 Changing basic body position 1 2 2 1 2
d415 Maintaining a body position 2 1 1
d430 Lifting and carrying objects 2 1 1 2 1 1
d440 Fine hand use (picking up) 1
d445 Hand and arm use 1
d450 Walking 5 1 9 3 3 3 1
d455 Moving around (climbing) 6 3 2 1 5 2 1 1 1
d460 Moving in different locations 2 1 1
d475 Driving (cycle) 1 1 1
d498 Mobility, other specified 3
d5 d510 Washing oneself 3 1 6 2 2 1 2 2 2 1
d520 Caring for body parts 3 1 1
d530 Toileting 2 1
d540 Dressing 2 1 3 2 1 1 2 2 1
d550 Eating 1 2
d6 d620 Shopping 1 1 3 1 1 1
d630 Preparing meals 3 2 1
d640 Doing housework 3 1 1 1 1 2 1 6 1 1
d649 Household task, unspecified 2
d650 Caring for household objects 3 1 1 1 1
d660 Assisting others 1 1 1
d7 d750 Informal social relationships 1 1
d760 Family relationships 1
d770 Intimate relationships 1 1 1
d8 d850 Remunerative employment 1
d859 Work, unspecified 1 1
d9 d910 Community life 1
d920 Recreation and leisure 8 1 4 2 2 4 2 1 2 2
d930 Religion and spirituality 1
The figures depict the number of items within the instrument that contained concepts linked to the respective ICF category.
Chapters: d2 (general tasks and demands), d3 (communication), d4 (mobility), d5 (self-care), d6 (domestic life), d7 (interpersonal
interactions and relationships), d8 (major life areas), d9 (community, social, and civic life).
Comparison of HRQL instruments for COPD 1119results of a recent international COPD survey.35 This study
showed, that 40–60% of COPD patients experience limita-
tions in normal physical exertion, sports and leisure
activities, as well as in household chores and social
activities.
However within these chapters, there was no category
covered by all instruments. In addition only a limited
number of the HRQL instruments address contents of the
chapters communication (d3), relationships (d7), or major
life areas (d8). For example, only the SGRQ and the AQ20
evaluate issues of employment and work. Since patients
with mild to moderate COPD may experience work-related
difficulties,4,6 the inclusion of such questions appears to be
justified. However, since essentially the large majority of
very severe COPD patients are old and retired, this might
explain that this issue is not addressed by the MRF 28 and
the LCADL. Similarly, speech difficulties are an importantcompromised function in COPD patients.35 It is therefore
surprising that talking limitations (d330) were addressed
only by four HRQL instruments (SGRQ, LCADL, MRF 28, CCQ).
The differences are most pronounced within the scarcely
covered contents on environmental factors. In view of the
fact that tobacco smoking and environmental pollution are
major risk factors for COPD, the restricted coverage of the
component ‘environmental factors’ is remarkable. The fact
that the SGRQ, QOL-RIQ, BPQ, and AQ20 address air quality
and climate aspects seems to be a particular strength of
these instruments.
When considering all instruments evaluated here there
are 21 items unique to specific instruments. These items
ultimately influence the choice of the instrument for a
specific clinical purpose.
The first question when selecting HRQL instruments for a
specific purpose is to decide what should be measured. For
ARTICLE IN PRESS
Table 6 Linkage of concepts from COPD-specific HRQL instruments to the respective ICF categories in the component
environmental factors.
ICF component body functions (b) Instruments
 Category SGRQ CRQ-SAS PFSDQ-M PFSS BPQ SOLDQ QOL-RIQ AQ20 LCADL MRF28 CCQ
e1 e110 Drugs (medication) 4 1
e115 Technology for personal use
(nebulizer, oxygen, respiratory device)
3 1
e2 e220 Flora and fauna 2
e225 Climate 1 5 3
e260 Air quality 1 2 2 1
e3 Support and relationship (global) 3 3 1
e310 Immediate family 1 1
e315 Extended family 1
e320 Friends 1
e355 Health professionals 1
The figures depict the number of items within the instrument that contained concepts linked to the respective ICF category.
Chapters: e1 (products and technology), e2 (natural environment and human-made changes to environment, e3 (support and
relationships), e4 (attitudes).
A. Stucki et al.1120this the study endpoints, the population studied, and the
intervention must be considered. The second question is to
decide which instrument to use from all the available
instruments. Since the ICF-based comparison provides
information about the contents addressed in the different
instruments, it may be a very useful tool in the selection
process. In the choice of a HRQL instrument further
considerations, such as practicability (e.g. interviewer vs.
self-administered instruments, standardized as opposed to
individualized items, length of the instrument, response
categories, and psychometric characteristics) have to be
then taken into account.
When selecting condition-specific instruments it would be
worthwhile to examine the overlap with generic HRQL
instruments. Such a comparison is possible through linkage
of the items to the ICF. Ideally, there would be only a
minimal overlap to minimize the number of questions that
need to be answered.
The linkage process has been evaluated by calculating
kappa coefficients, which showed satisfactory results for
linker agreement even though the groups consisted of
different professional backgrounds. Kappa is an often used
and simple indicator of agreement accounting for chance.
Several limitations apply to this study. First, the ICF was
not specifically designed for COPD resulting in the fact, that
three concepts were not represented by the ICF. These
concepts have been identified by this study and may be
incorporated in future versions of the ICF. Second, the four
concepts referring to ‘personal factors’ identified in the
instruments could not be linked since they are not yet
contained in the current ICF version. Third, the linkage
process revealed, that the category emotional factors
(b152) are addressed very frequently in the different
instruments, which may indicate that ICF does not differ-
entiate sufficiently in this context. For example, the most
common emotional states that may be specified in a future
version of the ICF are upset, fear, anxiousness, and
depressed states. Similarly, it would be better not to putthe symptoms dyspnea and wheezing into the same category
b460, but create two distinct categories.
It is important to emphasize that the results of the
content comparison of the HRQL instruments based on the
ICF cannot substitute a thorough study of the instruments
under consideration. The tables summarizing the results of
the content comparison do not provide information about
the kind of response categories that are applied or the
psychometric properties of the instruments.
The ICF provides an excellent framework when comparing
the content of HRQL instruments for COPD. This content
comparison provides valuable information to study the
heterogeneity and overlapping of the instruments regarding
their representation of body structures, body functions,
activities and participation, and environmental factors. The
comparison of these instruments provides interesting insight
into their similarities and differences and does so in a
detailed and structured way.
Our results somewhat contradict, at least in terms of the
ICF, previous assumptions made about COPD-specific HRQL
instruments—that ‘their content is generally similar’,14 that
‘all items in the questionnaire are common to all patients
with the disease’, and that ‘the items are those that reflect
the usual effect of the disease in a population of patients
with COPD’.15 The selection of an appropriate COPD-specific
HRQL instrument depends, among other considerations, on
the study question, the population to be studied, and the
intervention. No single COPD-specific HRQL instrument is
ideal for all applications. However, the first question to ask
when selecting a COPD-specific HRQL instrument is What
should be measured? This ICF-based content comparison can
help researchers and clinicians decide which tool to use.Conflict of interest statement
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